Table of Contents

company-logo

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Verrica Pharmaceuticals Dividend Announcement

• Verrica Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Verrica Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Verrica Pharmaceuticals Dividend History

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Verrica Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Verrica Pharmaceuticals Financial Ratios

P/E ratio-0.53
PEG ratio0.01
P/B ratio-1.32
ROE1303.74%
Payout ratio0.00%
Current ratio1.34
Quick ratio1.22
Cash Ratio1.09

Verrica Pharmaceuticals Dividend FAQ

Does Verrica Pharmaceuticals stock pay dividends?
Verrica Pharmaceuticals does not currently pay dividends to its shareholders.
Has Verrica Pharmaceuticals ever paid a dividend?
No, Verrica Pharmaceuticals has no a history of paying dividends to its shareholders. Verrica Pharmaceuticals is not known for its dividend payments.
Why doesn't Verrica Pharmaceuticals pay dividends?
There are several potential reasons why Verrica Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Verrica Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Verrica Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Verrica Pharmaceuticals a dividend aristocrat?
Verrica Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Verrica Pharmaceuticals a dividend king?
Verrica Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Verrica Pharmaceuticals a dividend stock?
No, Verrica Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Verrica Pharmaceuticals stocks?
To buy Verrica Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Verrica Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.